NCT07361705 2026-01-23Zorifertinib With Osimertinib for NSCLC With Meningeal ProgressionAlpha Biopharma (Jiangsu) Co., Ltd.Phase 1 Not yet recruiting42 enrolled
NCT06304441 2025-09-29Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung CancerGuangzhou Medical UniversityPhase NA Recruiting100 enrolled